APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis (Q73905009)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 2003

Language	Label	Description	Also known as
English	APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis	scientific article published on 01 September 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Alzheimer's disease

1 reference

based on heuristic

inferred from title

8

object named as

Bradley T Hyman

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2019

Martin Ingelsson

2

object named as

Martin Ingelsson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Hiroaki Fukumoto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Nina Gårevik

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lars Olof Wahlund

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Nobuyuki Nukina

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Yoshio Yaguchi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Masao Shibata

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G William Rebeck

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Michael C Irizarry

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Experimental Neurology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

183

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

249-253

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

The Clinical Dementia Rating scale: community-based validation of "profound' and "terminal' stages

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Abnormal in vivo metabolism of apolipoprotein E4 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E and the CNS response to injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Monoclonal antibody against the polymorphic site distinguishes apolipoprotein E4 from other isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Identification and characterization of apolipoprotein(AII-E2-AII) complex in human plasma lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Sandwich ELISA for the measurement of Apo-E4 levels in serum and the estimation of the allelic status of Apo-E4 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900088-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-4886(03)00088-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957508%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73905009&oldid=1984945916"